{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:19:12Z","timestamp":1794007152118,"version":"4.8.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009429","name":"Israel National Road Safety Authority","doi-asserted-by":"publisher","award":["F30MH115618"],"award-info":[{"award-number":["F30MH115618"]}],"id":[{"id":"10.13039\/100009429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS088479"],"award-info":[{"award-number":["R01 NS088479"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.neuropharm.2021.108624","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T11:25:18Z","timestamp":1622460318000},"page":"108624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["The diverse and complex modes of action of anti-NMDA receptor autoantibodies"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8179-1259","authenticated-orcid":false,"given":"Lonnie P.","family":"Wollmuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Groc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108624_bib1","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/s41467-018-06145-w","article-title":"A conserved glycine harboring disease-associated mutations permits NMDA receptor slow deactivation and high Ca(2+) permeability","volume":"9","author":"Amin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108624_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1113\/JP278705","article-title":"From bedside-to-bench: what disease-associated variants are teaching us about the NMDA receptor","volume":"599","author":"Amin","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1085\/jgp.201711762","article-title":"Divergent roles of a peripheral transmembrane segment in AMPA and NMDA receptors","volume":"149","author":"Amin","year":"2017","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib4","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2005.049486","article-title":"Hippocampal atrophy in systemic lupus erythematosus","volume":"65","author":"Appenzeller","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.neuropharm.2021.108624_bib5","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0896-6273(00)00094-5","article-title":"Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core","volume":"28","author":"Armstrong","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108624_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/341230a0","article-title":"NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus","volume":"341","author":"Bekkers","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108624_bib8","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.STR.0000221295.14547.c8","article-title":"NMDA receptor antibodies predict adverse neurological outcome after cardiac surgery in high-risk patients","volume":"37","author":"Bokesch","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2021.108624_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semarthrit.2012.03.011","article-title":"Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort","volume":"42","author":"Borowoy","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbi.2021.02.010","article-title":"Lupus-prone B6.Nba2 male and female mice display anti-DWEYS reactivity and a neuropsychiatric phenotype","volume":"94","author":"Browne","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108624_bib11","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/mp.2016.125","article-title":"All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class","volume":"22","author":"Castillo-Gomez","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108624_bib12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-020-15224-w","article-title":"Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory","volume":"11","author":"Chan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108624_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-D-Aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuropharm.2021.108624_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1523\/JNEUROSCI.3607-06.2007","article-title":"Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis","volume":"27","author":"Chen","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.579953","article-title":"Excitotoxicity: still hammering the ischemic brain in 2020","volume":"14","author":"Choi","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-319-57193-5_9","article-title":"Schizophrenia: basic and clinical","volume":"15","author":"Coyle","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108624_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108624_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"Degiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108624_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/WCO.0000000000000546","article-title":"Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease","volume":"31","author":"Ehrenreich","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib22","doi-asserted-by":"crossref","first-page":"18569","DOI":"10.1073\/pnas.1006980107","article-title":"Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms","volume":"107","author":"Faust","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108624_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"3","author":"Fragoso-Loyo","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108624_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/humu.24141","article-title":"GRIN database: a unified and manually curated repertoire of GRIN variants","volume":"42","author":"Garcia-Recio","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2021.108624_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.neuropharm.2021.108624_bib26","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","article-title":"Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain","volume":"32","author":"Gleichman","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib27","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1073\/pnas.1922563117","article-title":"Nanoscale co-organization and coactivation of AMPAR, NMDAR, and mGluR at excitatory synapses","volume":"117","author":"Goncalves","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108624_bib28","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/art.30616","article-title":"NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus erythematosus","volume":"63","author":"Gono","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.31887\/DCNS.2017.19.1\/mleboyer","article-title":"Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti-NMDA-receptor autoantibody","volume":"19","author":"Grea","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay4631","article-title":"Linking glutamate receptor movements and synapse function","volume":"368","author":"Groc","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108624_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nn1270","article-title":"Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors","volume":"7","author":"Groc","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib32","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.0605238103","article-title":"NMDA receptor surface mobility depends on NR2A-2B subunits","volume":"103","author":"Groc","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108624_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.25626","article-title":"N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse","volume":"29","author":"Hacohen","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2021.108624_bib34","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108624_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Review: nervous system disease in systemic lupus erythematosus: current status and future directions","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib36","first-page":"1553","article-title":"Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus","volume":"33","author":"Hanly","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.neuropharm.2021.108624_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7321-7_1","article-title":"NMDA receptors in the central nervous system","volume":"1677","author":"Hansen","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib40","series-title":"NMDA Receptor C-Terminal Signaling in Development, Plasticity, and Disease","first-page":"8","author":"Hardingham","year":"2019"},{"key":"10.1016\/j.neuropharm.2021.108624_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrn.2015.19","article-title":"Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis","volume":"17","author":"Hardingham","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib42","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/art.22030","article-title":"Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus","volume":"54","author":"Harrison","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-physiol-021014-071753","article-title":"Long-term potentiation: from CaMKII to AMPA receptor trafficking","volume":"78","author":"Herring","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fncel.2018.00391","article-title":"Mechanisms and role of dendritic membrane trafficking for long-term potentiation","volume":"12","author":"Hiester","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib45","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar4518","article-title":"Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"16","author":"Hirohata","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.neuropharm.2021.108624_bib46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13075-014-0450-z","article-title":"Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus","volume":"16","author":"Hirohata","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.neuropharm.2021.108624_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jphs.2016.10.002","article-title":"Human GRIN2B variants in neurodevelopmental disorders","volume":"132","author":"Hu","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108624_bib49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuron.2013.10.025","article-title":"AMPARs and synaptic plasticity: the last 25 years","volume":"80","author":"Huganir","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108624_bib50","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105161","article-title":"Autoimmunity and NMDA receptor in brain disorders: where do we stand?","volume":"147","author":"Hunter","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108624_bib52","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/ard.2004.029280","article-title":"Autoantibodies to a NR2A peptide of the glutamate\/NMDA receptor in sera of patients with systemic lupus erythematosus","volume":"64","author":"Husebye","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.neuropharm.2021.108624_bib53","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108624_bib54","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41467-017-01700-3","article-title":"Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients","volume":"8","author":"Jezequel","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108624_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1176\/appi.ajp.2017.17091053","article-title":"Molecular pathogenicity of anti-NMDA receptor autoantibody from patients with first-episode psychosis","volume":"175","author":"Jezequel","year":"2018","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108624_bib56","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1038\/tp.2017.162","article-title":"Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia","volume":"7","author":"Kannan","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108624_bib57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40478-017-0473-1","article-title":"Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling","volume":"5","author":"Kapadia","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neuropharm.2021.108624_bib58","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.180.3.925","article-title":"Mutational analysis of an autoantibody: differential binding and pathogenicity","volume":"180","author":"Katz","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2021.108624_bib59","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nn.3724","article-title":"Mechanical coupling maintains the fidelity of NMDA receptor-mediated currents","volume":"17","author":"Kazi","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuron.2018.09.012","article-title":"Differential nanoscale topography and functional role of GluN2-NMDA receptor subtypes at glutamatergic synapses","volume":"100","author":"Kellermayer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108624_bib61","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/art.40933","article-title":"Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials","volume":"71","author":"Kello","year":"2019","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12916-015-0269-8","article-title":"Neuropsychiatric lupus: a mosaic of clinical presentations","volume":"13","author":"Kivity","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2021.108624_bib63","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.7569905","article-title":"Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95","volume":"269","author":"Kornau","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108624_bib64","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108624_bib65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2021.108624_bib66","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108624_bib67","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.celrep.2018.05.096","article-title":"NMDA receptor autoantibodies in autoimmune encephalitis cause a subunit-specific nanoscale redistribution of NMDA receptors","volume":"23","author":"Ladepeche","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108624_bib68","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/art.38852","article-title":"Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjogren's syndrome","volume":"66","author":"Lauvsnes","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12916-016-0712-5","article-title":"Immuno-psychiatry: an agenda for clinical practice and innovative research","volume":"14","author":"Leboyer","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2021.108624_bib70","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","article-title":"Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study","volume":"4","author":"Lennox","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108624_bib71","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00702-014-1193-3","volume":"121","author":"Levite","year":"2014","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2021.108624_bib72","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0961203309351539","article-title":"Periodic lateralized epileptiform discharges in neuropsychiatric lupus: association with cerebritis in magnetic resonance imaging and resolution after intravenous immunoglobulin","volume":"19","author":"Lim","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.neuropharm.2021.108624_bib73","doi-asserted-by":"crossref","first-page":"28596","DOI":"10.1074\/jbc.R115.652750","article-title":"Dynamic regulation of N-Methyl-d-aspartate (NMDA) and alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by posttranslational modifications","volume":"290","author":"Lussier","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108624_bib74","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00415-018-9042-1","article-title":"Affinities of human NMDA receptor autoantibodies: implications for disease mechanisms and clinical diagnostics","volume":"265","author":"Ly","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124002","article-title":"Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment","volume":"4","author":"Mackay","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.neuropharm.2021.108624_bib76","series-title":"Racial\/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: the California Lupus Surveillance Project (CLSP)","author":"Maningding","year":"2019"},{"key":"10.1016\/j.neuropharm.2021.108624_bib77","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awaa195","article-title":"Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis","volume":"143","author":"Mannara","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108624_bib78","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1152\/jn.00458.2019","article-title":"Rapid exchange of synaptic and extrasynaptic NMDA receptors in hippocampal CA1 neurons","volume":"123","author":"Mcquate","year":"2020","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib79","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/brain\/aws092","article-title":"Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis","volume":"135","author":"Mikasova","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108624_bib80","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10067-004-1046-9","article-title":"Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature","volume":"24","author":"Milstone","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24195","article-title":"Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis","volume":"76","author":"Moscato","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib82","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1073\/pnas.1219454110","article-title":"Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression","volume":"110","author":"Nabavi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108624_bib83","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2021.108624_bib84","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1468-1331.2004.00976.x","article-title":"Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors","volume":"12","author":"Omdal","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib85","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41380-017-0011-3","article-title":"Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model","volume":"24","author":"Pan","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108624_bib86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib87","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2012.06.029","article-title":"Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists","volume":"150","author":"Papouin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108624_bib88","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0601","article-title":"Organization, control and function of extrasynaptic NMDA receptors","volume":"369","author":"Papouin","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib89","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108624_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044518","article-title":"Potentiation of NMDA receptor-dependent cell responses by extracellular high mobility group box 1 protein","volume":"7","author":"Pedrazzi","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108624_bib91","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3899\/jrheum.091366","article-title":"Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus","volume":"37","author":"Petri","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.24721","article-title":"Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity","volume":"80","author":"Planaguma","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib93","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planaguma","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108624_bib94","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneur.65.5.589","article-title":"Diagnostic and pathogenic significance of glutamate receptor autoantibodies","volume":"65","author":"Pleasure","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib95","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"Pruss","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib96","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2018.09.009","article-title":"Pathogenic role of autoantibodies against inhibitory synapses","volume":"1701","author":"Pruss","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108624_bib97","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1084\/jem.188.1.29","article-title":"Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition","volume":"188","author":"Putterman","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2021.108624_bib98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13041-020-0563-z","article-title":"Tripartite signalling by NMDA receptors","volume":"13","author":"Rajani","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2021.108624_bib99","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Rayes","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib100","first-page":"1161","article-title":"Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset","volume":"41","author":"Reveille","year":"1998","journal-title":"LUMINA Study Group"},{"key":"10.1016\/j.neuropharm.2021.108624_bib101","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.8036512","article-title":"Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis","volume":"265","author":"Rogers","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108624_bib102","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.neuron.2016.11.006","article-title":"Molecular basis for subtype specificity and high-affinity zinc inhibition in the GluN1-GluN2A NMDA receptor amino-terminal domain","volume":"92","author":"Romero-Hernandez","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108624_bib103","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/annrheumdis-2019-215098","article-title":"Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies","volume":"78","author":"Schwarting","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.neuropharm.2021.108624_bib104","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev.biochem.76.060805.160029","article-title":"The postsynaptic architecture of excitatory synapses: a more quantitative view","volume":"76","author":"Sheng","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108624_bib106","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2019.03.010","article-title":"NMDA receptor hypofunction for schizophrenia revisited: perspectives from epigenetic mechanisms","volume":"217","author":"Snyder","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2021.108624_bib107","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI122942","article-title":"Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica","volume":"129","author":"Soltys","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2021.108624_bib108","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1182\/blood-2016-05-719757","article-title":"C1q and HMGB1 reciprocally regulate human macrophage polarization","volume":"128","author":"Son","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2021.108624_bib109","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamapsychiatry.2014.469","article-title":"Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited","volume":"71","author":"Steiner","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108624_bib110","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/nn.4157","article-title":"Dendritic integration: 60 years of progress","volume":"18","author":"Stuart","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib111","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2015.07.038","article-title":"Schizophrenia: evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology","volume":"309","author":"Tamminga","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108624_bib112","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature19058","article-title":"A trans-synaptic nanocolumn aligns neurotransmitter release to receptors","volume":"536","author":"Tang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108624_bib113","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/epi.14662","article-title":"A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis","volume":"60","author":"Taraschenko","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108624_bib114","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2016.12.002","article-title":"Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjogren's syndrome: an updated meta-analysis","volume":"16","author":"Tay","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.neuropharm.2021.108624_bib115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib116","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0896-6273(02)00658-X","article-title":"Mobile NMDA receptors at hippocampal synapses","volume":"34","author":"Tovar","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108624_bib117","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108624_bib118","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108624_bib119","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"Tuzun","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.neuropharm.2021.108624_bib121","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2016.10.016","article-title":"Non-canonical signaling, the hidden life of ligand-gated ion channels","volume":"92","author":"Valbuena","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108624_bib122","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis","volume":"13","author":"Van Sonderen","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib123","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0959-4388(03)00073-4","article-title":"Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation","volume":"13","author":"Vanhoutte","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib124","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jnc.14970","article-title":"Regulation of NMDA glutamate receptor functions by the GluN2 subunits","volume":"154","author":"Vieira","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108624_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson's disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib126","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.3377-17.2018","article-title":"Positive allosteric modulation as a potential therapeutic strategy in anti-NMDA receptor encephalitis","volume":"38","author":"Warikoo","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib127","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.25460","article-title":"N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit","volume":"85","author":"Wenke","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108624_bib128","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cophys.2017.12.003","article-title":"Ion permeation in ionotropic glutamate receptors: still dynamic after all these years","volume":"2","author":"Wollmuth","year":"2018","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.neuropharm.2021.108624_bib129","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1523\/JNEUROSCI.6371-11.2012","article-title":"Synaptic NMDA receptors mediate hypoxic excitotoxic death","volume":"32","author":"Wroge","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108624_bib130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cophys.2017.12.013","article-title":"De novo mutations and rare variants occurring in NMDA receptors","volume":"2","author":"Xiangwei","year":"2018","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.neuropharm.2021.108624_bib131","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.yebeh.2017.03.023","article-title":"Effects of picrotoxin on zebrafish larvae behaviors: a comparison study with PTZ","volume":"70","author":"Yang","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2021.108624_bib132","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/STROKEAHA.114.008323","article-title":"Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke","volume":"46","author":"Zerche","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2021.108624_bib133","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaut.2009.03.011","article-title":"Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential","volume":"33","author":"Zhang","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.neuropharm.2021.108624_bib134","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1073858414548724","article-title":"Extrasynaptic NMDA receptor in excitotoxicity: function revisited","volume":"21","author":"Zhou","year":"2015","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2021.108624_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.82","article-title":"NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors","volume":"4","author":"Zhou","year":"2013","journal-title":"Cell Death Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:55:24Z","timestamp":1762214124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":135,"alternative-id":["S0028390821001787"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108624","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diverse and complex modes of action of anti-NMDA receptor autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108624"}}